Virginie Cérec

597 total citations
12 papers, 449 citations indexed

About

Virginie Cérec is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Virginie Cérec has authored 12 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Virginie Cérec's work include CAR-T cell therapy research (4 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). Virginie Cérec is often cited by papers focused on CAR-T cell therapy research (4 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). Virginie Cérec collaborates with scholars based in France, United Kingdom and United States. Virginie Cérec's co-authors include Denise Glaise, Anne Corlu, Christiane Guguen‐Guillouzo, Bernard Drénou, Dina Kremsdorf, Serban Morosan, Bruno Turlin, Philippe Gripon, Delphine Garnier and Robert Tidswell and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Hepatology.

In The Last Decade

Virginie Cérec

11 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Virginie Cérec France 7 193 122 114 85 72 12 449
Dieter Runge United States 12 262 1.4× 137 1.1× 258 2.3× 118 1.4× 196 2.7× 18 612
Maitane Asensio Spain 13 294 1.5× 253 2.1× 90 0.8× 25 0.3× 163 2.3× 18 605
Michael K. Connolly United States 7 107 0.6× 94 0.8× 197 1.7× 59 0.7× 78 1.1× 8 554
Walter Beerheide Singapore 10 212 1.1× 79 0.6× 114 1.0× 46 0.5× 79 1.1× 11 428
Wenchang Guo United States 11 347 1.8× 38 0.3× 39 0.3× 28 0.3× 46 0.6× 21 491
Xiong‐Zhi Wu China 12 190 1.0× 109 0.9× 122 1.1× 13 0.2× 58 0.8× 15 452
Jinggang Mo China 13 246 1.3× 87 0.7× 67 0.6× 16 0.2× 51 0.7× 36 516
Shuzhen Chen China 10 234 1.2× 109 0.9× 81 0.7× 21 0.2× 37 0.5× 13 481
Nanya Wang China 13 150 0.8× 148 1.2× 86 0.8× 13 0.2× 37 0.5× 29 450

Countries citing papers authored by Virginie Cérec

Since Specialization
Citations

This map shows the geographic impact of Virginie Cérec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginie Cérec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginie Cérec more than expected).

Fields of papers citing papers by Virginie Cérec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginie Cérec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginie Cérec. The network helps show where Virginie Cérec may publish in the future.

Co-authorship network of co-authors of Virginie Cérec

This figure shows the co-authorship network connecting the top 25 collaborators of Virginie Cérec. A scholar is included among the top collaborators of Virginie Cérec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginie Cérec. Virginie Cérec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Vos, Sven de, Patrick M. Reagan, Manish R. Patel, et al.. (2022). Magrolimab, Rituximab and Acalabrutinib for Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Results from the Phase 1 PRISM Trial. Blood. 140(Supplement 1). 6635–6637. 5 indexed citations
2.
Dubois‐Pot‐Schneider, Hélène, Caroline Aninat, Kathrin Kattler, et al.. (2022). Transcriptional and Epigenetic Consequences of DMSO Treatment on HepaRG Cells. Cells. 11(15). 2298–2298. 17 indexed citations
3.
Vargas, Frederick Arce, Claire Roddie, Paul Shaughnessy, et al.. (2021). Industrialization of an Academic Miltenyi Prodigy-Based CAR T Process. Blood. 138(Supplement 1). 477–477.
4.
Popat, Rakesh, Sonja Zweegman, Jim Cavet, et al.. (2019). Phase 1 First-in-Human Study of AUTO2, the First Chimeric Antigen Receptor (CAR) T Cell Targeting APRIL for Patients with Relapsed/Refractory Multiple Myeloma (RRMM). Blood. 134(Supplement_1). 3112–3112. 45 indexed citations
5.
Harb, Wael A., Virginie Cérec, Brian Champion, et al.. (2016). A phase I study of pembrolizumab in combination with enadenotucirev (EnAd) (SPICE) in subjects with metastatic or advanced carcinoma.. Journal of Clinical Oncology. 34(15_suppl). TPS3112–TPS3112. 3 indexed citations
6.
Madec, Stéphanie, Virginie Cérec, Emmanuelle Plée‐Gautier, et al.. (2011). CYP4F3B Expression Is Associated with Differentiation of HepaRG Human Hepatocytes and Unaffected by Fatty Acid Overload. Drug Metabolism and Disposition. 39(10). 1987–1996. 19 indexed citations
7.
Chapman, Michael H., Robert Tidswell, James Dooley, et al.. (2011). Whole genome RNA expression profiling of endoscopic biliary brushings provides data suitable for biomarker discovery in cholangiocarcinoma. Journal of Hepatology. 56(4). 877–885. 39 indexed citations
8.
Tomasi, Sophie, Jacques Renault, Bénédicte Martin, et al.. (2010). Targeting the Polyamine Transport System with Benzazepine- and Azepine-Polyamine Conjugates. Journal of Medicinal Chemistry. 53(21). 7647–7663. 32 indexed citations
9.
Cérec, Virginie, Fausto Andreola, & Stephen P. Pereira. (2009). Effect of verteporfin-PDT on the Notch signaling pathway in cholangiocarcinoma (CCA) cell lines. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 7380. 73806J–73806J. 1 indexed citations
10.
Cérec, Virginie, Denise Glaise, Delphine Garnier, et al.. (2007). Transdifferentiation of hepatocyte‐like cells from the human hepatoma HepaRG cell line through bipotent progenitor†. Hepatology. 45(4). 957–967. 279 indexed citations
11.
Cérec, Virginie, et al.. (2006). Multiple Pathways for Cationic Amino Acid Transport in Rat Seminiferous Tubule Cells1. Biology of Reproduction. 76(2). 241–249. 8 indexed citations
12.
Cérec, Virginie, Denise Glaise, Philippe Gripon, Christiane Guguen‐Guillouzo, & Anne Corlu. (2005). C020 - Capacité de transdifférenciation hépato-biliaire des cellules HepaRG issues d’un hépatocarcinome différencié et contrôles génétiques associés. Gastroentérologie Clinique et Biologique. 29(8-9). 893–893. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dieter Runge Breakdown of academic impact, for papers by Maitane Asensio Breakdown of academic impact, for papers by Michael K. Connolly Breakdown of academic impact, for papers by Walter Beerheide Breakdown of academic impact, for papers by Wenchang Guo Breakdown of academic impact, for papers by Xiong‐Zhi Wu Breakdown of academic impact, for papers by Jinggang Mo Breakdown of academic impact, for papers by Shuzhen Chen Breakdown of academic impact, for papers by Nanya Wang
Rankless by CCL
2026